| Bioactivity | B-Raf IN 19 (compound 31) is a BRAF inhibitor that inhibits BRAF(WT) and BRAF(V600E) (IC50: 0.57 μM and 0.28 μM, respectively). B-Raf IN 19 inhibits MAPK signaling in melanoma cells[1]. |
| CAS | 708218-62-6 |
| Formula | C20H15NO3S3 |
| Molar Mass | 413.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Qin J, et al. Identification of a novel family of BRAF(V600E) inhibitors. J Med Chem. 2012 Jun 14;55(11):5220-30. |
B-Raf IN 19
CAS: 708218-62-6 F: C20H15NO3S3 W: 413.53
B-Raf IN 19 (compound 31) is a BRAF inhibitor that inhibits BRAF(WT) and BRAF(V600E) (IC50: 0.57 μM and 0.28 μM, respe
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.